Market Place
Sourcing Support
Emcure Partners with Roche on Nephrology, Transplant Care
03 Mar 2026 //
INDPHARMAPOST
Roche`s Fenebrutinib Validates First BTK Inhibitor For MS
03 Mar 2026 //
GLOBENEWSWIRE
Signatera MRD Data at ASCO GU Support Use Across GU Cancers
27 Feb 2026 //
BUSINESSWIRE
Volta Labs Launches New Products, Partnerships at AGBT 2026
26 Feb 2026 //
PR NEWSWIRE
Another Setback For Enspryng As Roche Halts Duchenne Development
23 Feb 2026 //
FIERCE PHARMA
FDA accepts NDA for Roche’s giredestrant in ESR1-Mutated
23 Feb 2026 //
GLOBENEWSWIRE
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Roche Seeks Partner to Take Over Plant, Produce Key Antibiotic
23 Feb 2026 //
FIERCE PHARMA
Roche Announces Changes to Enlarged Executive Committee
17 Feb 2026 //
GLOBENEWSWIRE
Roche Announces Positive Phase III Results For Gazyva/Gazyvaro
17 Feb 2026 //
GLOBENEWSWIRE
Roche Unveils Data Behind BTK Inhibitor`s Phase 3 MS Win
09 Feb 2026 //
FIERCE BIOTECH
Delayed Notice Reveals 141 More Layoffs From Genentech In 2025
09 Feb 2026 //
BIOSPACE
Roche`s Fenebrutinib Reduces Disability Progression In Primary
07 Feb 2026 //
GLOBENEWSWIRE
OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
06 Feb 2026 //
FIERCE PHARMA
Biogen Bets HD Spinraza Can Outmuscle Roche`s Oral Rival
06 Feb 2026 //
FIERCE PHARMA
Chemometec Enters Letter Of Intent With Roche Diagnostics
04 Feb 2026 //
GLOBENEWSWIRE
Roche Continues RNA Return With $1.7B Deal For Sanegene Drug
03 Feb 2026 //
FIERCE BIOTECH
Roche Reports Strong 2025 Results: 7% Sales Growth
29 Jan 2026 //
GLOBENEWSWIRE
Roche Drops $100M Kiniksa Fibrosis Drug From Ph. 2 Pipeline
29 Jan 2026 //
FIERCE BIOTECH
Roche Eyes Busy 2026 Despite Vabysmo Miss, Tecentriq Flop
29 Jan 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
Roche Obesity Drug Shows 22.5% Weight Loss as Catch up With Lilly
28 Jan 2026 //
REUTERS
Roche Scales Genentech`s NC Obesity Drug Site To $2B
21 Jan 2026 //
FIERCE PHARMA
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Roche Spends $570M On Another ADC Agreement With China`s Medilink
09 Jan 2026 //
BIOSPACE
Medilink Inks Exclusive Licensing Deal With Roche
08 Jan 2026 //
PR NEWSWIRE
Ollin Eyes Phase 3 After Topping Vabysmo In Early-Stage Trial
08 Jan 2026 //
FIERCE BIOTECH
Roche Commits $100M To Keep Its GLP-1 Structure Sound
06 Jan 2026 //
FIERCE BIOTECH
FDA Approves Roche`s Lunsumio VELO For Subcutaneous Use
22 Dec 2025 //
GLOBENEWSWIRE
Roche CEO Points to Higher Future Drug Prices in Switzerland
20 Dec 2025 //
REUTERS
Caris, Genentech Collaborate on Novel Cancer Targets
16 Dec 2025 //
PR NEWSWIRE
FDA Approves Roche`s ENHERTU for HER2+ Metastatic Breast Cancer
16 Dec 2025 //
PR NEWSWIRE
Roche Launches Next-Gen Cobas 6800/8800 in U.S
16 Dec 2025 //
PR NEWSWIRE
Natera and MEDSIR to Collaborate on the MiRaDoR Trial
12 Dec 2025 //
BUSINESSWIRE
Roche Expands Mass Spectrometry Menu With Antibiotics Monitoring
11 Dec 2025 //
GLOBENEWSWIRE
Genentech`s Giredestrant Cuts Er-Positive Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Roche Links SERD to 30% Breast Cancer Risk Reduction in Phase 3
10 Dec 2025 //
GLOBENEWSWIRE
Genentech Uncovers `Hidden Gems` In Latest #Msvisibility Drive
09 Dec 2025 //
FIERCE PHARMA
Europe Approves Roche`s Gazyva For Active Lupus Nephritis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Launches CE-Marked PCR Test for Vaginitis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Reveals Lunsumio Data Suggesting Promise In Early Lymphoma
08 Dec 2025 //
GLOBENEWSWIRE
Genentech Reveals Lunsumio Data In Early Lymphoma Treatment Lines
08 Dec 2025 //
BUSINESSWIRE
Roche`s Columvi Combo Demonstrates Long-Term Survival Benefit
08 Dec 2025 //
GLOBENEWSWIRE
Orano Med Enters Next Phase Of Collaboration With Roche
04 Dec 2025 //
PHARMIWEB
Roche Whooping Cough Test Greenlighted In US, Europe
03 Dec 2025 //
FIERCE BIOTECH
Roche Reenters Alzheimer`s With New Antibody Clearing Amyloid
02 Dec 2025 //
BIOSPACE
Roche`s Alzheimer`s Reentry Marks A Pivotal Moment
02 Dec 2025 //
BIOSPACE
Actinium Reveals ATNM-400`s Strong Efficacy in Breast Cancer
01 Dec 2025 //
PR NEWSWIRE
Veeva Announces Expanded Partnership With Roche
24 Nov 2025 //
PR NEWSWIRE
Roche Inks $200M Pact For Freenome`s Cancer Screening Blood Test
21 Nov 2025 //
FIERCE BIOTECH
KaliVir & Roche Partner To Test VET3-TGI With Atezolizumab
19 Nov 2025 //
BUSINESSWIRE
European Commission Greenlights Roche`s Lunsumio Subcutaneous
19 Nov 2025 //
GLOBENEWSWIRE
Freenome & Roche Expand Cancer Screening Test Collaboration
18 Nov 2025 //
PR NEWSWIRE
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Poherdy, First Biosimilar To Roche`s Perjeta, Scores FDA Nod
14 Nov 2025 //
FIERCE PHARMA
NICE Endorses Roche`s Columvi For Earlier Use
13 Nov 2025 //
FIERCE PHARMA
Eirgenix Signs Commercial Licensing Deal For HER2 Biosimilar
12 Nov 2025 //
PR NEWSWIRE
Apollo 24|7 Partners With L`Oreal To Introduce La Roche-Posay
10 Nov 2025 //
ECONOMICTIMES
Roche`s Experimental MS Drug Hits Main Goal in One of Two Trial
09 Nov 2025 //
BUSINESSWIRE
Positive Phase III Data for Genentech’s Gazyva for Lupus
03 Nov 2025 //
BUSINESSWIRE
